| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/15/2004 | CA2491451A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | CA2491355A1 Controlled release compositions comprising coated pellets having non-uniform coating thicknesses |
| 01/15/2004 | CA2491257A1 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |
| 01/15/2004 | CA2491129A1 Central airway administration for systemic delivery of therapeutics |
| 01/15/2004 | CA2491128A1 Treatment for eye disorder |
| 01/15/2004 | CA2491054A1 Compositions of hyaluronic acid and methods of use |
| 01/15/2004 | CA2490978A1 Controlled-release pharmaceutical formulations |
| 01/15/2004 | CA2490959A1 Radiolabeled compounds and liposomes and their methods of making and using the same |
| 01/15/2004 | CA2490147A1 Liquid dosage forms of non-enterically coated proton pump inhibitors |
| 01/15/2004 | CA2490145A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | CA2490142A1 Liquid dosage forms of proton pump inhibitors |
| 01/15/2004 | CA2489919A1 Liposomal vaccine |
| 01/15/2004 | CA2489572A1 Extended-release tablets comprising divalproex sodium |
| 01/15/2004 | CA2489563A1 Compositions and methods for amelioration of human female sexual dysfunction |
| 01/15/2004 | CA2489071A1 Solid dispersions comprising two different polymer matrixes |
| 01/15/2004 | CA2488556A1 Combination therapy and means for carrying out said therapy |
| 01/14/2004 | EP1380639A1 Method for producing a water-alcohol solution and products based thereon |
| 01/14/2004 | EP1380595A1 Branched cyclic tetrassacharide, process for producing the same, and use |
| 01/14/2004 | EP1380308A1 Quickly disintegrable compression-molded materials and process for producing the same |
| 01/14/2004 | EP1380301A1 Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive |
| 01/14/2004 | EP1380297A1 8-chloro-6, 11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclo-hepta[1,2-b]pyridine oral compositions |
| 01/14/2004 | EP1380294A1 Preventive/remedial agent for inflammatory disease in oral-cavity mucosa and the like |
| 01/14/2004 | EP1380289A1 Delivery system for pharmaceutical agents |
| 01/14/2004 | EP1379640A1 Monochromatic fluid treatment systems |
| 01/14/2004 | EP1379575A1 Composition for soluble films with a new hydrolyzed polysaccharide |
| 01/14/2004 | EP1379513A1 Prodrugs of cox-2 inhibitors |
| 01/14/2004 | EP1379499A1 New diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 01/14/2004 | EP1379446A1 Water-soluble container having at least two openings |
| 01/14/2004 | EP1379337A1 Generation of pharmaceutical agent particles using focused acoustic energy |
| 01/14/2004 | EP1379306A1 Device for artificial respiration |
| 01/14/2004 | EP1379295A2 Implantable therapeutic substance delivery device having a permanent magnet solenoid pump |
| 01/14/2004 | EP1379279A1 Orally deliverable pharmaceutical composition comprising a drug of low water solubility (cox-2 inhibitor), a solvent, a fatty acid and an organic amine |
| 01/14/2004 | EP1379261A2 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| 01/14/2004 | EP1379242A1 Method for treatment of cancer and compositions for use therein |
| 01/14/2004 | EP1379229A2 A jasmonate pharmaceutical composition for treatment of cancer |
| 01/14/2004 | EP1379227A1 Microemulsions as precursors to solid nanoparticles |
| 01/14/2004 | EP1379226A2 Animal model for evaluating analgesics |
| 01/14/2004 | EP1379225A2 Novel medicament compositions based on anticholinergic agents and endothelin antagonists |
| 01/14/2004 | EP1379224A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 01/14/2004 | EP1379223A1 Dental formulation |
| 01/14/2004 | EP1379222A1 Orodispersible effervescent tablets |
| 01/14/2004 | EP1379221A2 Pharmaceutical product with reticulated crystalline microstructure |
| 01/14/2004 | EP1379220A2 Inhalation capsules |
| 01/14/2004 | EP1379219A2 Large, porous particles produced controlling humidity during a spray draying process |
| 01/14/2004 | EP1379207A1 Composition for freshening nostrils and sinus cavities |
| 01/14/2004 | EP1379203A1 Condom with an erectogenic composition |
| 01/14/2004 | EP1379197A1 Delivery of drugs from sustained release devices implanted in myocardial tissue or in the pericardial space |
| 01/14/2004 | EP1379161A2 Skin patch including a temperature sensor |
| 01/14/2004 | EP1379144A1 Chewing gum-containing tablet |
| 01/14/2004 | EP1379138A1 Liquid formulations for dermal application in treatment of parasitic insects in animals |
| 01/14/2004 | EP1379135A1 Formulations comprising entrapped active ingredients and uses thereof |
| 01/14/2004 | EP1379133A2 Two-phase processing of thermosensitive polymers for use as biomaterials |
| 01/14/2004 | EP1124534B1 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 01/14/2004 | EP1082117B1 A stabilized antihistamine syrup containing aminopolycarboxylic acid as stabilizer |
| 01/14/2004 | EP1056448B1 Pharmaceutical combinations containing tramadol |
| 01/14/2004 | EP1009394B1 New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, comprising formoterol |
| 01/14/2004 | EP1003475B1 Centre filled confectionery |
| 01/14/2004 | EP0998935B1 Fatty emulsions containing reducing sugar and method for sterilizing the same |
| 01/14/2004 | EP0996407B1 Adhesive plaster with microcapsules containing essences, and method for its preparation |
| 01/14/2004 | EP0968710B1 Plasters for percutaneous absorption |
| 01/14/2004 | EP0951280B1 Hydrophilic microparticles and methods to prepare same |
| 01/14/2004 | EP0941072B1 Method and apparatus for the coating of substrates for pharmaceutical use |
| 01/14/2004 | EP0934074B1 Use of ginkgo biloba flavonoidic extract comprising up to 1% of terpenes, associated with ceramides, for oral hygiene and compositions containing such extract |
| 01/14/2004 | EP0904128B1 Composition and system for iontophoretic transdermal delivery of drugs |
| 01/14/2004 | EP0758227B1 Modulated release from biocompatible polymers |
| 01/14/2004 | EP0755247B1 Hydrofluorocarbon propellant containing medicinal aerosols |
| 01/14/2004 | EP0705097B2 Incorporating poly-n-vinyl amide in a transdermal system |
| 01/14/2004 | CN2598575Y Multifunctional biological light-absorbing medium |
| 01/14/2004 | CN2598537Y Nanometer acupuncture point application sheet |
| 01/14/2004 | CN1468253A 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/14/2004 | CN1468252A 6.alpha., 9.alpha.-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/14/2004 | CN1468209A Stable salts of o-acetylsalicyclic with basic amino acids |
| 01/14/2004 | CN1468144A Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/14/2004 | CN1468120A Electro-powder |
| 01/14/2004 | CN1468112A The use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/14/2004 | CN1468107A Eye drops |
| 01/14/2004 | CN1468105A Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 01/14/2004 | CN1468104A Use, in combination, of a purine activity and a nonsteroidal anti-inflammatory drug for preparing an anti-thrombotic and/or anti-inflammatory drug |
| 01/14/2004 | CN1468101A Method for reducing or stopping smoking |
| 01/14/2004 | CN1468097A Compositions comprising modafinil compounds |
| 01/14/2004 | CN1468096A Pharmaceutical solutions of modafinil compounds |
| 01/14/2004 | CN1468095A Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 01/14/2004 | CN1468094A New pharmaceutical compositions containing epinastine and pseudoephedrine |
| 01/14/2004 | CN1468093A Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 01/14/2004 | CN1468091A Vaccine composition and stabilisation method |
| 01/14/2004 | CN1468090A Slow release pharmaceutical preparation and method of administering same |
| 01/14/2004 | CN1468089A Microparticles for delivery of the heterologous nucleic acids |
| 01/14/2004 | CN1467248A Biodegradable biopolymers, method for their preparation and functional materials constituted by these biopolymers |
| 01/14/2004 | CN1467234A Medical copolymerized hydrogel and preparation method thereof |
| 01/14/2004 | CN1466994A Compositions and therapeutic use |
| 01/14/2004 | CN1466993A Recombination ªá-interferon gelatin injection |
| 01/14/2004 | CN1466988A Chinese materia medica preparation for treating burn and scald and method for preparing the same |
| 01/14/2004 | CN1466987A Medicine for preventing SARS and influenza-propolis lozenge and complement synergy medicine |
| 01/14/2004 | CN1466983A Matrimony vine royal jelly capsule and method for preparing the same |
| 01/14/2004 | CN1466955A Composite biological active capsule and method for preparing the same |
| 01/14/2004 | CN1466946A Freeze-drying composition for injection |
| 01/14/2004 | CN1466945A Slow releasing micropill containing active component of indapamide and method for preparing the same |
| 01/14/2004 | CN1466944A Method for preparing nanometer suspension of DHA |
| 01/14/2004 | CN1134479C Process for producing polymer |
| 01/14/2004 | CN1134453C Process for preparing polymer water dispersate |